A study conducted during COVID-19 pandemic explored the effects of extending the intervals between implanted vascular access port flushing.

In this study, researchers analyzed a cohort of patients with advanced cancers who received a COVID-19 mRNA vaccine and were treated in a comprehensive cancer center in 2021.

A phase 2 trial evaluated the efficacy of nivolumab added to brachytherapy, external beam radiation therapy, and ADT in men with high-risk grade group 5 prostate cancer.

HealthDay News — A three-month supervised resistance training regimen yields meaningful functional gains in patients with breast cancer, regardless of surgical management of the breast and axilla, ...

Researchers sought to determine whether asciminib would have long-term benefit in patients with newly-diagnosed Philadelphia chromosome-positive chronic phase CML.

Investigators conducted a meta-analysis of 4 randomized controlled trials including a total of more than 1000 men with prostate cancer.

High symptom scores for tiredness, poor well-being, pain, and drowsiness may prompt AYA patients with cancer to seek medical assistance in dying.

Investigators conducted a retrospective analysis at 19 trial sites where patients received at least one dose of the KEYNOTE-522 regimen for triple-negative breast cancer.

Investigators conducted a population-based study to characterize treatment rates, trends, and factors associated with the treatment of mNSCLC in elderly patients.

Researchers developed a model to predict risk of TIPN in patients with early-stage cancer treated with a taxane regimen.

Researchers evaluated patient goals for breast reconstruction after mastectomy, including reconstructive technique, timing, and mastectomy indication.

In this study, researchers investigated the potential impacts of “shared decision-making” replacing universal HBV birth-dose vaccination on neonatal and later chronic HBV infections.